Preoperative Anti-VEGF Therapy During Vitrectomy

Manish Nagpal, MD, FRCS

Show Description +

Manish Nagpal, MD, FRCS (UK), shares highlights of his presentation on the role of preoperative anti-VEGF therapy used during vitrectomy for vitreous hemorrhage in relation to postoperative nonclearing vitreous hemorrhage and cystoid macular edema.

Posted: 8/09/2017

Keywords:

Vitrectomy

Up Next

Digitally Assisted Vitreoretinal Surgery

Marco Mura, MD

Novel Technique for Steroid Injection

Michael Singer, MD

Treatments for VMT

Nathan C. Steinle, MD

Remaining Cost Effective with 'Slurry' Kenalog

Susan M. Malinowski, MD

Novel Technique for Visual Recovery Testing

John B. Miller, MD

Real-World Outcomes of Anti-VEGF Therapy in DME

Thomas A. Ciulla, MD, MBA

Intraoperative OCT in Subretinal Therapeutic Delivery

Lejla Vajzovic, MD

Cytogenetics in Uveal Melanoma

Carol Shields, MD

Revisiting VISTA: Nonperfusion and Aflibercept

Charles Wykoff, MD, PhD

Açai-based Surgical Dye

Mauricio Maia, MD, PhD

DEL MAR: Phase 2, Stage 2

David S. Boyer, MD

Mapping Perfusion Density

Richard B. Rosen, MD, DSc(Hon)

Advances in Endoillumination

David Chow, MD

Back to All Videos

Preoperative Anti-VEGF Therapy During Vitrectomy

Manish Nagpal, MD, FRCS

Posted: 8/09/2017

Keywords:

Vitrectomy

Please log in to leave a comment.

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

Preoperative Anti-VEGF Therapy During Vitrectomy

Up Next

Preoperative Anti-VEGF Therapy During Vitrectomy

More From ASRS: 2017 Coverage